Article | December 15, 2020

Five Key Functional Challenges Can Affect Oral Drug Products With An Immediate Release Profile. Ready-To-Use Excipients Can Now Solve Them All.

By Dr. Matthias Wiehn, Global Product Manager Oral Excipients, Evonik

Article #12 December - Evonik.de_205

The market for oral drug products with an immediate release profile continues to move towards the development of more complex dosage forms that are designed to address specific functional or application requirements. In almost every case, the goal is to create oral drug products with functional coatings that are so easy to manufacture and administer that they will optimize patient acceptability and brand preference.

Evonik has been partnering with pharmaceutical companies to overcome a range of development and manufacturing challenges associated with immediate release dosage forms over many years. While each formulation is different based upon factors such as the API, processing method and patient population, we’ve found that customers most commonly want solutions to some combination of the following five key challenges.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: